Clinical Trials

LIGHT Phase 1-2 Trial — Solid Tumors:
Study of I-124-CLR1404 (aka “NM404″) in Advanced Solid Malignancies

LIGHT Phase 1-2 Trial — Lung Cancer:
I-124-CLR1404 (aka “NM404″) as an Imaging Agent in Patients With NSCLC

LIGHT Phase 1-2 Trial — Metastatic Brain Cancer:
PET/CT Imaging of Malignant Brain Tumors With a Novel Radioiodinated Phospholipid Ether Analogue I-124-CLR1404 (aka “NM404″)

LIGHT Phase 1-2 Trial — Brain Cancer:
PET/CT Evaluation of Primary and Metastatic Brain Tumors With a Novel Radioiodinated Phospholipid Ether Analogue I-124-CLR1404 (aka “NM404″)

HOT Phase 1b Trial — Solid Tumors:
Dose Escalation Study of I-131-CLR1404 in Subjects With Cancer That Does Not Respond to Treatment or Has Returned